InspireMD, Inc. NSPR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.77M | 3.40M | 3.15M | 2.52M | 1.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.77M | 3.40M | 3.15M | 2.52M | 1.78M |
| Cost of Revenue | 2.55M | 2.71M | 1.97M | 1.66M | 1.47M |
| Gross Profit | -774.00K | 687.00K | 1.18M | 864.00K | 313.00K |
| SG&A Expenses | 9.38M | 9.90M | 9.79M | 10.28M | 9.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.22M | 17.38M | 15.23M | 15.57M | 14.80M |
| Operating Income | -14.45M | -13.98M | -12.08M | -13.05M | -13.02M |
| Income Before Tax | -14.32M | -13.69M | -11.70M | -12.71M | -13.15M |
| Income Tax Expenses | -- | -- | 63.00K | -- | -- |
| Earnings from Continuing Operations | -14.32M | -13.69M | -11.76M | -12.71M | -13.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.32M | -13.69M | -11.76M | -12.71M | -13.15M |
| EBIT | -14.45M | -13.98M | -12.08M | -13.05M | -13.02M |
| EBITDA | -14.29M | -13.83M | -11.94M | -12.92M | -12.91M |
| EPS Basic | -0.17 | -0.16 | -0.14 | -0.17 | -0.26 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.09 | -0.11 | -0.16 |
| EPS Diluted | -0.17 | -0.16 | -0.14 | -0.17 | -0.26 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.09 | -0.11 | -0.16 |
| Average Basic Shares Outstanding | 84.66M | 83.80M | 82.37M | 73.47M | 51.00M |
| Average Diluted Shares Outstanding | 84.66M | 83.80M | 82.37M | 73.47M | 51.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |